{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-029392","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2024-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.382970+00:00","generated_at":"2026-05-31T04:18:03.688283+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Reviva awards FY2023 bonuses: CEO $157,500, CFO $95,940, VP $77,376 in options","bullets":["FY2023 incentive bonuses for named executive officers paid as immediately vested stock options in lieu of cash.","CEO Laxminarayan Bhat granted 158,451 options at $1.20 per share; bonus value $157,500.","CFO Narayan Prabhu granted 96,519 options at $1.20 per share; bonus value $95,940.","VP Seema Bhat granted 77,843 options at $1.20 per share; bonus value $77,376."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-029392","json":"https://secwatch.observer/filing/0001437749-24-029392.json","markdown":"https://secwatch.observer/filing/0001437749-24-029392.md","text":"https://secwatch.observer/filing/0001437749-24-029392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924029392/0001437749-24-029392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924029392/rvph20240917_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:18:03.688283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}